Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association

Cardio-Oncology: Vascular and Metabolic Perspectives

Cardiovascular Disease and Breast Cancer: Where These Entities Intersect

Induced Pluripotent Stem Cells for Cardiovascular Disease Modeling and Precision Medicine

Interdisciplinary Models for Research and Clinical Endeavors in Genomic Medicine

The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction

Future Translational Applications from the Contemporary Genomics Era

Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy